Roche & Sanofi
6 shared events · Importance 3 · Last updated Jul 29, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Roche: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Sanofi: Sanofi is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Tech
Roche: Roche collaborates with Nurix on bexobrutideg development and co-commercialization in the US; the trial strengthens its oncology pipeline.
Sanofi: Sanofi collaborates with Nurix on a STAT6 degrader, but this event does not directly affect that program.
Aug 04, 2026 · 6 articles
Business
Roche: Roche gains co-development and co-commercialization rights to bexobrutideg, a potential best-in-class BTK degrader, expanding its pipeline in oncology, immunology, and neurology.
Sanofi: Sanofi has a separate collaboration with Nurix for a STAT6 degrader, but is not directly involved in this event.
Jul 21, 2026 · 6 articles
Business
Roche: Roche is a partner of Orano in developing targeted alpha therapies, suggesting potential for future collaboration and expansion in the oncology market.
Sanofi: Sanofi is a partner of Orano in developing targeted alpha therapies, indicating potential future collaboration and market opportunities in cancer treatment.
Jul 01, 2026 · 9 articles
Tech
Sanofi: Sanofi is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Roche and Sanofi interact across events, view sentiment trends, and discover connected entities.
Open Dashboard